Venus Concept Past Earnings Performance

Past criteria checks 0/6

Venus Concept has been growing earnings at an average annual rate of 11.1%, while the Medical Equipment industry saw earnings growing at 12% annually. Revenues have been declining at an average rate of 5.5% per year.

Key information

11.1%

Earnings growth rate

69.1%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate-5.5%
Return on equity-471.4%
Net Margin-74.6%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

It's A Story Of Risk Vs Reward With Venus Concept Inc. (NASDAQ:VERO)

Aug 29
It's A Story Of Risk Vs Reward With Venus Concept Inc. (NASDAQ:VERO)

Would Venus Concept (NASDAQ:VERO) Be Better Off With Less Debt?

May 12
Would Venus Concept (NASDAQ:VERO) Be Better Off With Less Debt?

Some Venus Concept Inc. (NASDAQ:VERO) Analysts Just Made A Major Cut To Next Year's Estimates

Mar 29
Some Venus Concept Inc. (NASDAQ:VERO) Analysts Just Made A Major Cut To Next Year's Estimates

Revenue & Expenses Breakdown

How Venus Concept makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqCM:VERO Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2467-50677
30 Jun 2470-50687
31 Mar 2473-37717
31 Dec 2376-37728
30 Sep 2383-36769
30 Jun 2386-428110
31 Mar 2394-458711
31 Dec 2299-449011
30 Sep 22108-389112
30 Jun 22111-339011
31 Mar 22109-228510
31 Dec 21106-238210
30 Sep 2199-33808
30 Jun 2195-31748
31 Mar 2186-44727
31 Dec 2078-85748
30 Sep 2084-91888
30 Jun 2090-93978
31 Mar 20100-861039
31 Dec 19110-41998
30 Sep 19107-33848
30 Jun 19107-26788
31 Mar 19106-19718
31 Dec 18103-15677
31 Dec 17893506
31 Dec 1653-13425

Quality Earnings: VERO is currently unprofitable.

Growing Profit Margin: VERO is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: VERO is unprofitable, but has reduced losses over the past 5 years at a rate of 11.1% per year.

Accelerating Growth: Unable to compare VERO's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: VERO is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.4%).


Return on Equity

High ROE: VERO has a negative Return on Equity (-471.44%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies